Drug Topics

JULY 8, 2024

Researchers addressed the association between semaglutide use and the risk of nonarteritic anterior ischemic optic neuropathy.

200

200

STAT

JULY 8, 2024

A study published Monday provides new evidence that the H5N1 virus currently causing an outbreak of bird flu in U.S. dairy cattle may be adapted to better infecting humans than other circulating strains of the virus, a result that is already courting controversy among the world’s leading flu researchers. Across the globe, different influenza viruses are constantly circulating in many different kinds of animals.

145

145

Drug Topics

JULY 8, 2024

Current recommendations suggest women receive the RSV vaccine between 32 and 36 weeks' gestational age.

Vaccines 145

Vaccines 145

STAT

JULY 8, 2024

Imagine this post-9/11 scenario: A New York City fire company is forced to shut down and lay off its firefighters because some Americans believe a bizarre conspiracy theory that this fire company brought down the World Trade Center towers. A Covid-19 version of this freakish tale is happening today. Instead of a fire company, the conspiracy gang is targeting an important, successful, decades-old nonprofit organization that researches viral epidemics and tries to predict and forestall future 

145

145

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Fierce Healthcare

JULY 8, 2024

U.S. digital health startups pulled in $5.7 billion across 266 deals in the first six months of 2024, marking continued momentum in the sector after a rocky few quarters last year. | U.S. digital health startups pulled in $5.7 billion across 266 deals in the first six months of 2024, marking continued momentum in the sector after a rocky few quarters last year.

138

138

STAT

JULY 8, 2024

Come quickly, the Columbus Police sergeant urged, patients are in danger. The psychiatric hospital on the city’s east side may need to be shut down, he warned Ohio regulators. The officer, a 27-year veteran of the department, knew that sending the February letter was an unusual thing to do, but meetings with hospital leaders had gone nowhere, and he was at his wit’s end.

Hospitals 145

Hospitals 145

STAT

JULY 8, 2024

Medical milestones broadcast via tweet. Scientific progress revealed via live YouTube demo. Teasers for updates followed by a livestream from a patient’s home. These aren’t the latest social media influencer tactics, but the way Neuralink, Elon Musk’s neurotechnology company, has disseminated information about its medical research.

Communication 144

Communication 144

Fierce Pharma

JULY 8, 2024

Is Eli Lilly’s Mounjaro or Novo Nordisk’s Ozempic more effective in helping patients lose weight? | Is Eli Lilly’s Mounjaro or Novo Nordisk’s Ozempic more effective in helping patients lose weight? While a head-to-head trial pitting the two treatments remains ongoing, new evidence shows that Lilly’s tirzepatide may be the superior weight loss product.

135

135

STAT

JULY 8, 2024

In a long-awaited study, patients in Australia will soon receive an IV infusion designed to transform their own immune cells into swarms of cancer-fighting drones. The trial, announced on Tuesday by Interius Biotherapeutics, will be the first to test what’s known technically as in vivo CAR-T therapy. Researchers have long hoped the approach could provide a potentially cheaper, safer, and more scalable version of the cell therapies that are curative for some blood cancer patients but remai

Immunization 144

Immunization 144

Pharmacy Times

JULY 8, 2024

Early diagnosis and comprehensive treatment may lead to full recovery for patients.

132

132

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

JULY 8, 2024

Bird flu snapshot: This is the latest installment in a series of regular updates on H5N1 avian flu that STAT is publishing on Monday mornings. To read future updates, you can also subscribe to STAT’s Morning Rounds newsletter. Last week, following an unusually udder pun-laden discussion , lawmakers in Delaware voted to become the latest state to legalize the sale of raw milk.

143

143

Fierce Healthcare

JULY 8, 2024

Healthcare industry groups are urging the federal government to streamline and loosen a recent proposed rule outlining cybersecurity incident reporting requirements for entities considered to be cr | Hospitals, practices, information management executives and even insurers criticized a proposed rule for its overlap with other federal reporting requirements and limited oversight of smaller third-parties, among other concerns.

Insurance 127

Insurance Hospitals 127

STAT

JULY 8, 2024

The Biden administration has appealed a decision in which a federal court jury last year sided with Gilead Sciences over the rights to a pair of groundbreaking HIV pills — and at least $1 billion in royalties may be at stake. At issue is a battle over patents for Truvada and a newer, upgraded version version called Descovy — two highly effective and lucrative medications — as well as the role played by the federal government in making it possible to prevent transmission of a

141

141

Fierce Healthcare

JULY 8, 2024

The portion of physicians surveyed by the American Medical Association (AMA) who report at least one symptom of burnout has dropped below 50%, a first since the onset of the COVID-19 pandemic. | The American Medical Association, which often cites burnout as a key threat to the well-being of the profession and the long-term supply of medical professionals, celebrated the results but said there’s still work to be done.

123

123

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

JULY 8, 2024

South African antitrust authorities ended an investigation into Johnson & Johnson and its Janssen subsidiary over “excessive pricing” of a lifesaving tuberculosis drug after the companies took steps to lower the cost and widen access to the medicine. In a brief statement , the Competition Commission explained that J&J and Janssen agreed not to enforce a so-called secondary patent on bedaquiline, which is also sold under the brand name Sirturo, a step that makes it possible

135

135

Fierce Healthcare

JULY 8, 2024

In a study published in JAMA Network Open on Tuesday, Included Health and Harvard Medical School found that patients in high deductible health plans are less likely to seek virtual behavioral healt | A study by Included Health and Harvard Medical School found that when cost-sharing is reintroduced for telehealth visits for patients in high-deductible health plans, patients will use fewer services.

Medical Schools 123

Medical Schools 123

STAT

JULY 8, 2024

Funding for health tech startups in the first half of 2024 remained far below the high levels seen immediately after the Covid-19 pandemic, but several indicators suggest stability — and maybe even a brewing comeback for the sector. Health tech startups raised $5.7 billion in the first half of the year, putting them on pace to just exceed the $10.7 billion total raised in 2023, according to a report from Rock Health , which invests in companies and provides advisory services.

124

124

Fierce Healthcare

JULY 8, 2024

A variety of government and healthcare organizations are now eligible to tap into newly announced funding by the Department of Health and Human Services. | The funding will support community-based maternal behavioral health services and a women’s behavioral health technical assistance center.

120

120

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Pharma

JULY 8, 2024

After a drawn-out litigation process, Merck & Co. seems to have finally washed its hands of more than a thousand lawsuits tied to its shingles vaccine Zostavax. | A U.S. appeals court has tossed a request to resurrect certain lawsuits claiming Merck’s popular shot Zostavax caused patients to develop shingles. The court made its decision after the plaintiffs filed a voluntary dismissal some two years after logging a loss in Pennsylvania.

Vaccines 118

Vaccines 118

Fierce Healthcare

JULY 8, 2024

Two high-ranking government officials have abdicated their roles on the board of the Coalition for Health AI, the organization and HHS confirmed. The breakup is a strong departure from th | Micky Tripathi and Troy Tazbaz have officially stepped down from their Board-level federal liaison roles at the Coalition for Health AI, one of the nation's largest healthcare AI standards organizations.

FDA 120

FDA 120

STAT

JULY 8, 2024

You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money in medicine. Sign up to get it in your inbox every Monday. Lifting the veil on psychiatric hospital joint ventures Nonprofit hospital systems are opening psychiatric hospitals to help the growing number of people suffering from mental  health  problems.

Hospitals 117

Hospitals 117

Fierce Healthcare

JULY 8, 2024

Nearly 5 million fewer people delayed care from 2019 to 2022, a study from the Urban Institute with funding from the Robert Wood Johnson Foundation revealed. | Pandemic-era policies appear to have helped almost 5 million people access necessary medical care that they otherwise may not have been able to, a recent report shows.

117

117

STAT

JULY 8, 2024

Eli Lilly said Monday it will acquire Morphic Holding, a biotech developing a treatment for inflammatory bowel disease. Lilly will pay about $3.2 billion to buy the Waltham, Mass.-based company. That translates to $57 per share, a premium of roughly 79% from Morphic’s Friday closing price. Morphic’s lead candidate, MORF-057, is an oral small molecule that blocks α4β7 integrin.

117

117

pharmaphorum

JULY 8, 2024

GLP-1 agonists like Novo Nordisk's Ozempic reduce the risk of 10 of 13 cancers associated with obesity in an observational study.

114

114

Fierce Pharma

JULY 8, 2024

As the process surrounding Medicare's drug price negotiations rolls on this summer—and as the pharmaceutical industry continues to loudly voice its complaints—another lawsuit contesting the legal v | Boehringer Ingelheim joins AstraZeneca, J&J and Bristol Myers Squibb in having a case challenging Medicare price negotiations fail to bear fruit.

113

113

Drug Topics

JULY 8, 2024

Results of a new survey show that individuals with dry eye believe the condition is something “people must learn to live with.

112

112

STAT

JULY 8, 2024

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of phone calls, online meetings, and deadlines has returned. But you knew this would happen, yes? After all, the world — such as it is — continues to spin. So we will make an effort to nudge it in a better direction by brewing a few cups of stimulation.

Pharmaceutical Companies 112

Pharmaceutical Companies Pharmaceutical Companies Hospitals 112

Fierce Pharma

JULY 8, 2024

Since Roche gained approval for its eye disease medication Vabysmo in 2022, it has stormed a market dominated by Regeneron and Bayer’s Eylea. | Since Roche gained approval for its eye disease medication Vabysmo in 2022, it has stormed a market dominated by Regeneron and Bayer’s Eylea. Roche has taken another step in its advancement of the blockbuster medicine, scoring an FDA nod to provide it in a prefilled syringe.

FDA 111

FDA 111

pharmaphorum

JULY 8, 2024

An observational study has suggested that Lilly’s tirzepatide is better at achieving weight loss than Novo Nordisk's semaglutide

111

111

Pharmacy Times

JULY 8, 2024

ADI-270 is a gamma delta CAR T-cell therapy candidate targeting CD70-positive cancers.

FDA 111

FDA 111

pharmaphorum

JULY 8, 2024

Eli Lilly boosts its inflammatory bowel disease pipeline with a $3.

111

111

Fierce Pharma

JULY 8, 2024

After announcing plans last year to expand manufacturing in its home country, Korean CDMO newcomer Lotte Biologics has kicked off work on a sprawling facility along Incheon’s waterfront near Seoul. | Late last week, Lotte Biologics broke ground on its flagship facility at the Songdo Bio Campus in Incheon International City, South Korea. The company is pitching the production effort as a key part of its quest to become one of the top 10 CDMOs in the world.

111

111

pharmaphorum

JULY 8, 2024

Myricx Bio taps into the red-hot interest in companies working on antibody-drug conjugates (ADCs) for cancer, raising £90m in its Series A

111

111